One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...
In 1967, the primordial Porsche 911 Carrera T was free of luxuries such as electronic fuel injection, power windows, and ...
The Porsche 911 entered the hybrid era for the 2025 model year, but it hasn’t given up the keys to its old place in the ...
Vall d’Hebron and del Mar hospitals expect to start in 2025 the first clinical trial of a new CAR-T therapy that has cured ...
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
Researchers at Saint Louis University's School of Medicine say T-cell dysfunction is leading to an increased risk of cancer ...
CART-007, an anti-CD7 CAR T-cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia or T-cell lymphoblastic ...
Bristol Myers reports promising preliminary results for its next-gen CAR T therapy CC-97540, showing safety and early efficacy in a Phase 1 study for severe autoimmune diseases.
Researchers developed SNIPRs, innovative receptors that sense soluble ligands, enabling precise therapeutic control in CAR ...
As declarações dos protagonistas do Projeto SHARP, do NOVA Center for Global Health, um grupo de reflexão que conta com o ...
Projeto SHARP, do NOVA Center for Global Health, vai produzir um relatório com recomendações para expandir a utilização de ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback